17:03 EDT Biodexa Pharmaceuticals (BDRX) files $100M mixed securities shelf
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDRX:
- Biodexa Pharmaceuticals Advances Serenta Trial and Secures Financial Backing
- Biodexa says requirement for financing represents ‘material uncertainty’
- Biodexa Pharmaceuticals reports 1H EPS (GBP0.0002) vs. (GBP0.001) last year
- Biodexa Pharmaceuticals Begins Phase 3 Trial for FAP Treatment
- Biodexa announces enrollment of first two patients in Phase 3 Serenta trial